An interview with Nancy Valente, the Global Head of Hematology Development at Roche

Expert Rev Hematol. 2020 Sep;13(9):929-932. doi: 10.1080/17474086.2020.1798612. Epub 2020 Jul 28.

Author

Nancy Valente¹

Affiliation

¹ Product Development, Global Head of Hematology Development at Roche , San Francisco, CA, USA.

PMID: 32684001
DOI: 10.1080/17474086.2020.1798612

No abstract available

Keywords: Hemlibra; Oncology; Polivy; antibody-drug conjugates; bispecific antibodies; crovalimab; hematology.

Publication types

Interview